Dow reported Q4 2025 EBITDA of $741M and guided Q1 2026 EBITDA to ~$750M, roughly flat sequentially. The call focused on self-help: a $1B cost savings program, a new 'Transform to Outperform' restructuring targeting $2B EBITDA uplift, and a two-year delay (to late 2029) for the Path to Zero Alberta project. Management struck a neutral tone, citing persistent macro headwinds but incremental progress on cost and capacity rationalization. Q4 2025 operating EBITDA of $741M was in line with seasonal expectations; Q1 2026 guide of ~$750M implies modest sequential improvement.
Buzzberg readTransform to Outperform targets $2B EBITDA upliftDow reported Q4 2025 EBITDA of $741M and guided Q1 2026 EBITDA to ~$750M, roughly flat sequentially. The call focused on self-help: a $1B cost savings program, a new 'Transform to Outperform' restructuring targeting $2B EBITDA uplift, and a two-year delay (to late 2029) for the Path to Zero Alberta project. Management struck a neutral tone, citing persistent macro headwinds but incremental progress on cost and capacity rationalization. Q4 2025 operating EBITDA of $741M was in line with seasonal expectations; Q1 2026 guide of ~$750M implies modest sequential improvement.Read full analysisCollapse analysis
Dow reported Q4 2025 EBITDA of $741M and guided Q1 2026 EBITDA to ~$750M, roughly flat sequentially. The call focused on self-help: a $1B cost savings program, a new 'Transform to Outperform' restructuring targeting $2B EBITDA uplift, and a two-year delay (to late 2029) for the Path to Zero Alberta project. Management struck a neutral tone, citing persistent macro headwinds but incremental progress on cost and capacity rationalization. Q4 2025 operating EBITDA of $741M was in line with seasonal expectations; Q1 2026 guide of ~$750M implies modest sequential improvement.
Transform to Outperform program aims for $2B near-term EBITDA uplift (~$500M in 2026) from productivity and growth, with 4,500 workforce reduction.
Path to Zero Alberta project delayed two years (phase 1 startup end-2029); returns guided at 8-10%, plus potential low-carbon premiums.
Shutdown of PO unit in Freeport removed ~20% of NA capacity; continued European asset rationalization (Barrie, UK siloxanes by mid-2026).
Revenue$9.46B
-5% QoQ
EPS$-0.34
reported
Gross margin5.79%
reported
Op margin-11.04%
reported
What changed this quarter
01
Guidance
Transform to Outperform targets $2B EBITDA uplift
Guidance tone
02
Costs
Dow to cut 4,500 roles globally
Q4 2025 operating EBITDA of $741M was in line with seasonal expectations; Q1 2026 guide of ~$750M implies modest sequential improvement.
03
Capex
Path to Zero delayed to late 2029
Dow is maintaining capital discipline with 2026 capex around $2.5 billion, keeping spending at or below depreciation until mid-cycle earnings improve. The Path to Zero project in Alberta is delayed two years to align with market recovery, with returns now expected at 8-10%, and…
04
Guidance
1Q26 EBITDA guidance $750M
Guidance tone
AI, capex & demand read
AI
Platform & monetization
Management emphasized leveraging automation and AI to streamline end-to-end work processes, reduce costs, and improve efficiency across the organization as part of the Transform to Outperform program. They see AI as a key enabler for productivity gains, with examples in legal, patent research, and turnaround maintenance.
Demand
Bookings & conversion
Management's tone is cautiously optimistic about self-help actions and cost savings, but acknowledges persistent macro challenges; the EBITDA guidance for Q1 2026 is roughly flat sequentially, indicating no material inflection yet.
Capex
Investment and capacity
Dow is maintaining capital discipline with 2026 capex around $2.5 billion, keeping spending at or below depreciation until mid-cycle earnings improve. The Path to Zero project in Alberta is delayed two years to align with market recovery, with returns now expected at 8-10%, and the company remains open to partnerships or creative financing to enhance value.
Tone · Measured
Management acknowledged persistent macroeconomic challenges and weak demand but emphasized disciplined execution, self-help actions, and strategic transformations to position for future recovery.
Supply-chain alpha
A1
Dow shut down a propylene oxide unit in Freeport, Texas, representing ~20% of North American PO capacity, tightening supply in a pressured market.
“we also completed the shutdown of our higher cost upstream propylene oxide unit in Freeport, Texas, rationalizing approximately 20% of North American PO industry capacity.”
Dow closed a large infrastructure partnership with Macquarie, providing cash proceeds and financial flexibility; no further business trajectory for Macquarie was signaled.
“we received approximately $3 billion in total cash proceeds for our strategic partnership with Macquarie for the sale of a 49% equity stake and select U.S. Gulf Coast infrastructure assets.”
… addition to this, our cash and cash equivalence balance was above $3.8 billion at the end of 2025. And Dow has approximately $14 billion of available liquidity, including a revolving credit facility that was recently renewed through 2030. And in 2025, we completed multiple actions to strengthen Dallas' near-term cash flow, further reinforce our balance sheet, and achieve lasting operational improvements. For example, we received approximately $3 billion in total cash proceeds for our strategic partnership with Macquarie for the sale of a 49% equity stake and select U.S. Gulf Coast infrastructure assets. We lowered our cost by more than $400 million in the year. and we lowered our CapEx plans by $1 billion. In addition to that, we completed two bond issuances at attractive spreads for a total of $2.4 billion, pushing our next material maturity to 2029. And we made the prudent decision to implement a 50% dividend reduction. Collectively, the actions we took provide near-term financial flexibility and support while maintaining our commitment to an investment-grade credit profile. Our teams will continue this momentum into 2026. This starts with delivering approximately $1 billion …
🍪 Cookies
We use cookies to operate this site and for analytics. Declining won't affect your access to content.